Premium
Omalizumab: a new add‐on therapy for severe asthma
Author(s) -
Corrigan Chris
Publication year - 2006
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.394
Subject(s) - omalizumab , medicine , asthma , intensive care medicine , clinical trial , immunoglobulin e , antibody , immunology
Omalizumab is a new injectable antibody for use in patients with severe asthma who are poorly controlled on existing therapies. Dr Corrigan describes the clinical trial results of its efficacy and side‐effects, and explains how it is administered. Copyright © 2006 Wiley Interface Ltd